» Articles » PMID: 3883904

High Titers of Antibodies to Single-stranded DNA in Linear Scleroderma

Overview
Journal Arch Dermatol
Specialty Dermatology
Date 1985 Mar 1
PMID 3883904
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Seven patients with severe linear scleroderma were initially found to have antibodies to double-stranded DNA (dsDNA) in higher titers, using the Farr technique. These patients, however, lacked the systemic involvement normally accompanying such antibodies. A detailed investigation of their sera using Crithidia luciliae assay and single-stranded DNA (ssDNA) labeled with iodine 131 disclosed high titers of antibodies to ssDNA and absent dsDNA antibodies. The ssDNA antibody titer was considerably higher than the mean for unselected patients with systemic lupus erythematosus. It is possible that these antibodies define a subgroup of patients with linear scleroderma who have more severe and extensive involvement of skin and underlying tissues.

Citing Articles

National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients.

Branton S, Stubbs L, Havrilla H, Torok K J Scleroderma Relat Disord. 2024; :23971983241272460.

PMID: 39544906 PMC: 11559527. DOI: 10.1177/23971983241272460.


Morphea and Eosinophilic Fasciitis: An Update.

Mertens J, Seyger M, Thurlings R, Radstake T, de Jong E Am J Clin Dermatol. 2017; 18(4):491-512.

PMID: 28303481 PMC: 5506513. DOI: 10.1007/s40257-017-0269-x.


Major histocompatibility complex class I and class II alleles may confer susceptibility to or protection against morphea: findings from the Morphea in Adults and Children cohort.

Jacobe H, Ahn C, Arnett F, Reveille J Arthritis Rheumatol. 2014; 66(11):3170-7.

PMID: 25223600 PMC: 4211936. DOI: 10.1002/art.38814.


Morphea in adults and children cohort III: nested case-control study--the clinical significance of autoantibodies in morphea.

Dharamsi J, Victor S, Aguwa N, Ahn C, Arnett F, Mayes M JAMA Dermatol. 2013; 149(10):1159-65.

PMID: 23925398 PMC: 4153681. DOI: 10.1001/jamadermatol.2013.4207.


Systemic and localized scleroderma in children: current and future treatment options.

Rosenkranz M, Agle L, Efthimiou P, Lehman T Paediatr Drugs. 2006; 8(2):85-97.

PMID: 16608370 DOI: 10.2165/00148581-200608020-00002.